- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07534553
Mechanical Power Ventilation in RALP
Mechanical Power-Targeted Ventilation in Robot-Assisted Laparoscopic Radical Prostatectomy: A Prospective Randomized Controlled Trial
Robot-assisted laparoscopic radical prostatectomy (RALP) requires steep Trendelenburg positioning and pneumoperitoneum, which adversely affect respiratory mechanics and may lead to impaired postoperative oxygenation.
Mechanical power (MP) has recently emerged as a comprehensive parameter reflecting the total energy delivered from the ventilator to the respiratory system and may be associated with ventilator-induced lung injury.
This prospective randomized controlled trial aims to evaluate whether a mechanical power-targeted ventilation strategy improves postoperative oxygenation compared to standard ventilation in patients undergoing RALP.
The primary outcome is the oxygenation index (OSI) at the postoperative second hour. Secondary outcomes include PaO₂/FiO₂ ratio, postoperative pulmonary complications, and length of hospital stay.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Betül Güven Aytaç, Assos prof
- Phone Number: 0905073578351
- Email: drbguven@hotmail.com
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Ankara Bilkent City Hospital
-
Contact:
- Betül Güven Aytaç, Assos prof
- Phone Number: 0905073578351
- Email: drbguven@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years
- Elective RALP
- ASA I-III
Exclusion Criteria:
Severe pulmonary disease (advanced COPD, ILD)
- Preoperative oxygen requirement
- Emergency surgery
- BMI > 40 kg/m²
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mechanical Power-Targeted Ventilation
Patients receive ventilation adjusted to achieve the lowest possible mechanical power (≤14 J/min) by titrating PEEP and respiratory rate.
|
Ventilation adjusted to achieve the lowest possible mechanical power (≤14 J/min) using titration of PEEP and respiratory rate.
Conventional ventilation strategy with fixed PEEP (5 cmH₂O) and routine settings.
|
|
Active Comparator: Standard Ventilation
Patients receive conventional ventilation with fixed PEEP (5 cmH₂O) and routine ventilator settings.
|
Ventilation adjusted to achieve the lowest possible mechanical power (≤14 J/min) using titration of PEEP and respiratory rate.
Conventional ventilation strategy with fixed PEEP (5 cmH₂O) and routine settings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygenation Index (OSI)
Time Frame: postoperative 2nd hour
|
OSI calculation: OSI = FiO₂ × MAP × 100 / SpO₂ |
postoperative 2nd hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaO₂/FiO₂ ratio
Time Frame: Intraoperative period and postoperative 2 hours
|
Intraoperative period and postoperative 2 hours
|
|
|
Postoperative pulmonary complications (PPC)
Time Frame: Within 7 postoperative days
|
Within 7 postoperative days
|
|
|
Intraoperative respiratory mechanics
Time Frame: During surgery (from intubation to extubation)
|
Dynamic compliance (Cdyn, mL/cmH₂O) Static compliance (Cstat, mL/cmH₂O) Peak airway pressure (Ppeak, cmH₂O) Plateau pressure (Pplat, cmH₂O) Driving pressure (ΔP = Pplat - PEEP, cmH₂O) Mean airway pressure (MAP, cmH₂O) Airway resistance
|
During surgery (from intubation to extubation)
|
|
Mechanical power changes
Time Frame: During surgery (at predefined intraoperative time points)
|
During surgery (at predefined intraoperative time points)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- E2-26-14834
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.